CD31 defines a subpopulation of human adipose-derived regenerative cells with potent angiogenic effects

Abstract Cellular heterogeneity represents a major challenge for regenerative treatment using freshly isolated Adipose Derived Regenerative Cells (ADRCs). Emerging data suggest superior efficacy of ADRCs as compared to the ex vivo expanded and more homogeneous ADRCs (= ASCs) for indications involvin...

Full description

Bibliographic Details
Main Authors: Pratibha Dhumale, Jakob Vennike Nielsen, Anne Cathrine Schmidt Hansen, Mark Burton, Hans Christian Beck, Mads Gustaf Jørgensen, Navid Mohamadpour Toyserkani, Martha Kirstine Haahr, Sabrina Toft Hansen, Lars Lund, Mads Thomassen, Jens Ahm Sørensen, Ditte Caroline Andersen, Charlotte Harken Jensen, Søren Paludan Sheikh
Format: Article
Language:English
Published: Nature Portfolio 2023-09-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-41535-1
_version_ 1797559839795183616
author Pratibha Dhumale
Jakob Vennike Nielsen
Anne Cathrine Schmidt Hansen
Mark Burton
Hans Christian Beck
Mads Gustaf Jørgensen
Navid Mohamadpour Toyserkani
Martha Kirstine Haahr
Sabrina Toft Hansen
Lars Lund
Mads Thomassen
Jens Ahm Sørensen
Ditte Caroline Andersen
Charlotte Harken Jensen
Søren Paludan Sheikh
author_facet Pratibha Dhumale
Jakob Vennike Nielsen
Anne Cathrine Schmidt Hansen
Mark Burton
Hans Christian Beck
Mads Gustaf Jørgensen
Navid Mohamadpour Toyserkani
Martha Kirstine Haahr
Sabrina Toft Hansen
Lars Lund
Mads Thomassen
Jens Ahm Sørensen
Ditte Caroline Andersen
Charlotte Harken Jensen
Søren Paludan Sheikh
author_sort Pratibha Dhumale
collection DOAJ
description Abstract Cellular heterogeneity represents a major challenge for regenerative treatment using freshly isolated Adipose Derived Regenerative Cells (ADRCs). Emerging data suggest superior efficacy of ADRCs as compared to the ex vivo expanded and more homogeneous ADRCs (= ASCs) for indications involving (micro)vascular deficiency, however, it remains unknown which ADRC cell subtypes account for the improvement. Surprisingly, we found regarding erectile dysfunction (ED) that the number of injected CD31+  ADRCs correlated positively with erectile function 12 months after one bolus of autologous ADRCs. Comprehensive in vitro and ex vivo analyses confirmed superior pro-angiogenic and paracrine effects of human CD31+ enriched ADRCs compared to the corresponding CD31− and parent ADRCs. When CD31+, CD31− and ADRCs were co-cultured in aortic ring- and corpus cavernous tube formation assays, the CD31+  ADRCs induced significantly higher tube development. This effect was corroborated using conditioned medium (CM), while quantitative mass spectrometric analysis suggested that this is likely explained by secretory pro-angiogenic proteins including DKK3, ANGPT2, ANAX2 and VIM, all enriched in CD31+  ADRC CM. Single-cell RNA sequencing showed that transcripts of the upregulated and secreted proteins were present in 9 endothelial ADRC subsets including endothelial progenitor cells in the heterogenous non-cultured ADRCs. Our data suggest that the vascular benefit of using ADRCs in regenerative medicine is dictated by CD31+  ADRCs.
first_indexed 2024-03-10T17:50:59Z
format Article
id doaj.art-8349d1f1a861482c933e74589114bbd7
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-03-10T17:50:59Z
publishDate 2023-09-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-8349d1f1a861482c933e74589114bbd72023-11-20T09:21:11ZengNature PortfolioScientific Reports2045-23222023-09-0113111710.1038/s41598-023-41535-1CD31 defines a subpopulation of human adipose-derived regenerative cells with potent angiogenic effectsPratibha Dhumale0Jakob Vennike Nielsen1Anne Cathrine Schmidt Hansen2Mark Burton3Hans Christian Beck4Mads Gustaf Jørgensen5Navid Mohamadpour Toyserkani6Martha Kirstine Haahr7Sabrina Toft Hansen8Lars Lund9Mads Thomassen10Jens Ahm Sørensen11Ditte Caroline Andersen12Charlotte Harken Jensen13Søren Paludan Sheikh14Department of Clinical Research, University of Southern Denmark (SDU)Department of Clinical Biochemistry, Odense University Hospital (OUH)Department of Clinical Biochemistry, Odense University Hospital (OUH)Department of Clinical Genetics, OUHDepartment of Clinical Research, University of Southern Denmark (SDU)Department of Clinical Research, University of Southern Denmark (SDU)Department of Plastic Surgery, OUHDepartment of Urology, OUHDepartment of Clinical Research, University of Southern Denmark (SDU)Department of Clinical Research, University of Southern Denmark (SDU)Department of Clinical Research, University of Southern Denmark (SDU)Department of Clinical Research, University of Southern Denmark (SDU)Department of Clinical Research, University of Southern Denmark (SDU)Department of Clinical Research, University of Southern Denmark (SDU)Department of Clinical Research, University of Southern Denmark (SDU)Abstract Cellular heterogeneity represents a major challenge for regenerative treatment using freshly isolated Adipose Derived Regenerative Cells (ADRCs). Emerging data suggest superior efficacy of ADRCs as compared to the ex vivo expanded and more homogeneous ADRCs (= ASCs) for indications involving (micro)vascular deficiency, however, it remains unknown which ADRC cell subtypes account for the improvement. Surprisingly, we found regarding erectile dysfunction (ED) that the number of injected CD31+  ADRCs correlated positively with erectile function 12 months after one bolus of autologous ADRCs. Comprehensive in vitro and ex vivo analyses confirmed superior pro-angiogenic and paracrine effects of human CD31+ enriched ADRCs compared to the corresponding CD31− and parent ADRCs. When CD31+, CD31− and ADRCs were co-cultured in aortic ring- and corpus cavernous tube formation assays, the CD31+  ADRCs induced significantly higher tube development. This effect was corroborated using conditioned medium (CM), while quantitative mass spectrometric analysis suggested that this is likely explained by secretory pro-angiogenic proteins including DKK3, ANGPT2, ANAX2 and VIM, all enriched in CD31+  ADRC CM. Single-cell RNA sequencing showed that transcripts of the upregulated and secreted proteins were present in 9 endothelial ADRC subsets including endothelial progenitor cells in the heterogenous non-cultured ADRCs. Our data suggest that the vascular benefit of using ADRCs in regenerative medicine is dictated by CD31+  ADRCs.https://doi.org/10.1038/s41598-023-41535-1
spellingShingle Pratibha Dhumale
Jakob Vennike Nielsen
Anne Cathrine Schmidt Hansen
Mark Burton
Hans Christian Beck
Mads Gustaf Jørgensen
Navid Mohamadpour Toyserkani
Martha Kirstine Haahr
Sabrina Toft Hansen
Lars Lund
Mads Thomassen
Jens Ahm Sørensen
Ditte Caroline Andersen
Charlotte Harken Jensen
Søren Paludan Sheikh
CD31 defines a subpopulation of human adipose-derived regenerative cells with potent angiogenic effects
Scientific Reports
title CD31 defines a subpopulation of human adipose-derived regenerative cells with potent angiogenic effects
title_full CD31 defines a subpopulation of human adipose-derived regenerative cells with potent angiogenic effects
title_fullStr CD31 defines a subpopulation of human adipose-derived regenerative cells with potent angiogenic effects
title_full_unstemmed CD31 defines a subpopulation of human adipose-derived regenerative cells with potent angiogenic effects
title_short CD31 defines a subpopulation of human adipose-derived regenerative cells with potent angiogenic effects
title_sort cd31 defines a subpopulation of human adipose derived regenerative cells with potent angiogenic effects
url https://doi.org/10.1038/s41598-023-41535-1
work_keys_str_mv AT pratibhadhumale cd31definesasubpopulationofhumanadiposederivedregenerativecellswithpotentangiogeniceffects
AT jakobvennikenielsen cd31definesasubpopulationofhumanadiposederivedregenerativecellswithpotentangiogeniceffects
AT annecathrineschmidthansen cd31definesasubpopulationofhumanadiposederivedregenerativecellswithpotentangiogeniceffects
AT markburton cd31definesasubpopulationofhumanadiposederivedregenerativecellswithpotentangiogeniceffects
AT hanschristianbeck cd31definesasubpopulationofhumanadiposederivedregenerativecellswithpotentangiogeniceffects
AT madsgustafjørgensen cd31definesasubpopulationofhumanadiposederivedregenerativecellswithpotentangiogeniceffects
AT navidmohamadpourtoyserkani cd31definesasubpopulationofhumanadiposederivedregenerativecellswithpotentangiogeniceffects
AT marthakirstinehaahr cd31definesasubpopulationofhumanadiposederivedregenerativecellswithpotentangiogeniceffects
AT sabrinatofthansen cd31definesasubpopulationofhumanadiposederivedregenerativecellswithpotentangiogeniceffects
AT larslund cd31definesasubpopulationofhumanadiposederivedregenerativecellswithpotentangiogeniceffects
AT madsthomassen cd31definesasubpopulationofhumanadiposederivedregenerativecellswithpotentangiogeniceffects
AT jensahmsørensen cd31definesasubpopulationofhumanadiposederivedregenerativecellswithpotentangiogeniceffects
AT dittecarolineandersen cd31definesasubpopulationofhumanadiposederivedregenerativecellswithpotentangiogeniceffects
AT charlotteharkenjensen cd31definesasubpopulationofhumanadiposederivedregenerativecellswithpotentangiogeniceffects
AT sørenpaludansheikh cd31definesasubpopulationofhumanadiposederivedregenerativecellswithpotentangiogeniceffects